Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "Africa"

334 News Found

Novavax and Serum file EUA for Covovax in South Africa
Biotech | January 10, 2022

Novavax and Serum file EUA for Covovax in South Africa

Novavax' vaccine has received authorizations of the vaccine in over 170 countries


Moderna to build mRNA facility in Africa
Biotech | October 07, 2021

Moderna to build mRNA facility in Africa

The aim is to first produce Covid-19 vaccines and then add more vaccines in the years to come


Fredun Pharma bags Rs 22 crore order from East African countries
News | September 15, 2021

Fredun Pharma bags Rs 22 crore order from East African countries

The order strengthens the company’s position in the East African market


Dabur profit jumps 16% as FMCG growth gains pace
News | May 08, 2026

Dabur profit jumps 16% as FMCG growth gains pace

Hair care & quick commerce shine


Ajanta Pharma Q4 FY26 revenue surges 21% to Rs. 1,422 Crore; PAT climbs 18%
News | May 06, 2026

Ajanta Pharma Q4 FY26 revenue surges 21% to Rs. 1,422 Crore; PAT climbs 18%

FY26 revenue rises 17% to Rs. 5,453 crore as US generics business jumps 49% and adjusted EBITDA margin improves to 26% for the quarter


Microbot Medical expands LIBERTY Robotic System commercial rollout
Medical Device | May 05, 2026

Microbot Medical expands LIBERTY Robotic System commercial rollout

The company secured new accounts, including ACCESS-PVI trial sites, and aims to strengthen global commercialization efforts


Indoco Remedies to exit ophthalmic business in strategic sale to Sunways India
News | May 02, 2026

Indoco Remedies to exit ophthalmic business in strategic sale to Sunways India

The transaction marks a clear portfolio reshuffle for Indoco


Fabtech Technologies FY26 revenue rises 28% to Rs 431 crore
News | May 01, 2026

Fabtech Technologies FY26 revenue rises 28% to Rs 431 crore

Pharma and biotech infrastructure firm targets 25–30% growth as Middle East and Africa emerge as key expansion markets


Local manufacturing, deeper CDMO ties, region-specific solutions remain our top priorities in next 3–5 years: Ganesh Bade,  Head Bioprocessing, India, Avantor
interviews | April 24, 2026

Local manufacturing, deeper CDMO ties, region-specific solutions remain our top priorities in next 3–5 years: Ganesh Bade, Head Bioprocessing, India, Avantor

Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region


Gujarat Themis Biosyn to acquire anti-TB and anti-infective brands from Sanofi for EUR 158 Million
News | April 24, 2026

Gujarat Themis Biosyn to acquire anti-TB and anti-infective brands from Sanofi for EUR 158 Million

Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence